495Tip A Phase II Study Evaluating the Safety and Efficacy of ENV-101 (taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Annals of Oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2022)